Global iPSC Service Market Growth (Status and Outlook) 2024-2030
iPSC Service (induced pluripotent stem cell service) is a professional service involving the generation, cultivation and application of induced pluripotent stem cells (iPSCs). These cells transform somatic cells (such as skin cells) into pluripotent stem cells through genetic reprogramming technology, which can differentiate into various types of cells and are widely used in disease modeling, drug screening, regenerative medicine and gene therapy research.
The global iPSC Service market size is projected to grow from US$ 116 million in 2024 to US$ 195 million in 2030; it is expected to grow at a CAGR of 9.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “iPSC Service Industry Forecast” looks at past sales and reviews total world iPSC Service sales in 2022, providing a comprehensive analysis by region and market sector of projected iPSC Service sales for 2023 through 2029. With iPSC Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC Service industry.
This Insight Report provides a comprehensive analysis of the global iPSC Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC Service.
As the technology matures and its application scope expands, the demand for iPSC services is growing, especially in drug toxicity testing, genetic disease research, and cell replacement therapy. North America and Europe are the main markets, but the Asia-Pacific region, especially China and Japan, is rapidly becoming an important driver of growth, and the global market is expected to continue to grow in the next few years.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
iPSC Manufacturing Services
iPSC Differentiation Service
iPSC Reprogramming Service
Others
Segmentation by Application:
Disease Modeling
Drug Screening
Regenerative Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
iPSC Manufacturing Services
iPSC Differentiation Service
iPSC Reprogramming Service
Others
Segmentation by Application:
Disease Modeling
Drug Screening
Regenerative Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Charles River
Creative Biolabs
Reprocell
Sampled
Elixirgen Scientific
CellSystems
AXOL Bioscience
ALSTEM
Amsterdam UMC
Cellected
Please note: The report will take approximately 2 business days to prepare and deliver.